Literature DB >> 18356047

Synthesis of 17beta-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines.

Josée Provencher-Mandeville1, Caroline Descôteaux, Sanat K Mandal, Valérie Leblanc, Eric Asselin, Gervais Bérubé.   

Abstract

The synthesis of a series of 17beta-estradiol-platinum(II) hybrid molecules is reported. The hybrids are made of a PEG linking chain of various length and a 2-(2'-aminoethyl)pyridine ligand. They are prepared from estrone in five chemical steps with an overall yield of 22%. The length of the PEG chain does not influence the solubility of the compounds as it remains relatively constant throughout the series. MTT assays showed that the derivative with the longest PEG chain showed the best activity against breast cancer cell lines (MCF-7 and MDA-MB-231). Molecular modeling study rationalized the results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356047     DOI: 10.1016/j.bmcl.2008.03.005

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

2.  Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells.

Authors:  Kuan-Wei Peng; Huali Wang; Zhihui Qin; Gihani T Wijewickrama; Meiling Lu; Zhican Wang; Judy L Bolton; Gregory R J Thatcher
Journal:  ACS Chem Biol       Date:  2009-12-18       Impact factor: 5.100

3.  Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes.

Authors:  Stephen Barrett; Michele De Franco; Andrew Kellett; Eithne Dempsey; Cristina Marzano; Andrea Erxleben; Valentina Gandin; Diego Montagner
Journal:  J Biol Inorg Chem       Date:  2019-10-26       Impact factor: 3.358

4.  Promising Hybrids Derived from S-Allylcysteine and NSAIDs Fragments against Colorectal Cancer: Synthesis, In-vitro Evaluation, Drug-Likeness and In-silico ADME/tox Studies.

Authors:  Angie Herrera-R; Wilson Castrillón; Manuel Pastrana; Andres F Yepes; Wilson Cardona-G
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

5.  New Hybrids Based on Curcumin and Resveratrol: Synthesis, Cytotoxicity and Antiproliferative Activity against Colorectal Cancer Cells.

Authors:  Cristian Hernández; Gustavo Moreno; Angie Herrera-R; Wilson Cardona-G
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

6.  Synthesis and in-vitro Evaluation of S-allyl Cysteine Ester - Caffeic Acid Amide Hybrids as Potential Anticancer Agents.

Authors:  Wilson Castrillón; Angie Herrera-R; Laura Juliana Prieto; Laura Conesa-Milián; Miguel Carda; Tonny Naranjo; Maria Elena Maldonado; Wilson Cardona-G
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.